Medtronic PLC’s CoreValve self-expandingtranscatheter aortic valve made regulatory headway in both Japan and the U.S. March 30.
CoreValve is closer to being able to compete with Edwards Lifesciences Corp.’s Sapien XT TAVR system for the first time in the large Japanese market after gaining regulatory approval...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?